Drug profile · INN
sargramostim
IMREPLYS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sargramostim (IMREPLYS) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN sargramostim
Brand IMREPLYS
Formulation VIAL
ATC code L03AA09
Frequently asked questions
What is sargramostim?
sargramostim (IMREPLYS) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for sargramostim?
IMREPLYS is a marketed brand name for sargramostim. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sargramostim?
sargramostim has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.